Long-term follow-up of very preterm infants with NEC or bowel perforation
Part of Digestive system, Women’s health & pregnancy clinical trials.
This study looks at the long-term health of very preterm infants who had a serious gut condition called necrotizing enterocolitis (NEC) or a bowel perforation between 2008 and 2013. Researchers will compare their development to similar infants without these conditions to understand long-term outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child was born very preterm (before 32 weeks of pregnancy) in Norway between 2008 and 2013.
- Your child was diagnosed with surgical NEC (a serious gut infection) or a bowel perforation.
- Your child survived to at least one year of age.
- You are willing to provide written informed consent for participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the intestines grow and develop in both premature and full-term babies. It involves collecting small tissue samples during a baby's already-planned surgery or scope procedure to better understand normal development and digestive diseases.
This study interviews surgeons who treat infants with a serious bowel condition called necrotising enterocolitis (NEC). Researchers want to understand how surgeons make decisions and how babies do afterward.
This study looks at newborns (up to 28 days old) who have urgent stomach or intestinal problems needing immediate treatment. Researchers want to understand what types of emergencies happen most often and how babies fare after treatment.
This study looks at whether newborns with necrotizing enterocolitis (a serious bowel infection) develop allergies differently than healthy newborns. Researchers will compare allergen sensitivity between babies who had this condition and those who didn't, to better understand how the illness affects the immune system.
This study tests an investigational drug called ST266 in babies with necrotizing enterocolitis (NEC), a serious gut infection. The goal is to see if it is safe and can help heal the bowel.
This study tests a new system to catch a serious bowel infection called necrotizing enterocolitis (NEC) early in premature babies. By identifying warning signs sooner, doctors hope to prevent severe complications and improve outcomes.
Hear when a new Necrotizing Enterocolitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.